FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2015/02/005583 [Registered on: 26/02/2015] Trial Registered Prospectively
Last Modified On: 15/06/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Use of dexmedetomidine with local anaesthetic for stellate ganglion block in patients scheduled for upper limb surgeries and its effect on requirement of post operative pain relieving drug. 
Scientific Title of Study   Tramadol sparing effect of dexmedetomidine as an adjuvant in preoperative stellate ganglion block in patients undergoing upper limb surgeries 
Trial Acronym  SGB 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Deepak Thapa 
Designation  Associate Professor 
Affiliation  Govt Medical College And Hospital Chandigarh 
Address  Department of Anaesthesia Govt Medical College And Hospital Sector 32 Chandigarh

Chandigarh
CHANDIGARH
160030
India 
Phone  9646121524  
Fax    
Email  dpkthapa@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Deepanshu Dhiman 
Designation  post graduate resident 
Affiliation  Govt Medical College And Hospital Chandigarh 
Address  Department of Anaesthesia Govt Medical College And Hospital Sector 32 Chandigarh

Chandigarh
CHANDIGARH
160030
India 
Phone  9646308822  
Fax    
Email  panshu88@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Deepak Thapa 
Designation  Associate Professor 
Affiliation  Govt Medical College And Hospital Chandigarh 
Address  Department of Anaesthesia Govt Medical College And Hospital Sector 32 Chandigarh

Chandigarh
CHANDIGARH
160030
India 
Phone  9646121524  
Fax    
Email  dpkthapa@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesia Govt Medical College And Hospital Chandigarh 
 
Primary Sponsor  
Name  Department of Anaesthesia 
Address  Department of Anaesthesia Govt Medical College and Hospital Sector 32 Chandigarh 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Deepak Thapa  Department of Anaesthesia   Govt Medical College And Hospital Sector 32 Chandigarh
Chandigarh
CHANDIGARH 
9646121524

dpkthapa@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M958||Other specified acquired deformities of musculoskeletal system, Patients undergoing upper limb surgeries,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group 1- patients will receive preoperative stellate ganglion block with 3.5 ml of a solution(3 ml of 2% lignocaine plus 0.5 micrograms/kg dexmedetomidine plus normal saline to make a final volume of 3.5 ml ) and 15 ml of sterile normal saline by intravenous route.  Patients will receive ultrasound guided preoperative stellate ganglion block with 3.5 ml of a solution(3 ml of 2% lignocaine plus 0.5 micrograms/kg dexmedetomidine plus normal saline to make a final volume of 3.5 ml ) and 15 ml of sterile normal saline by intravenous route. 
Comparator Agent  Group 2- patients will receive preoperative stellate ganglion block with 3.5 ml of solution (3 ml 2 % lignocaine plus 0.5 ml of normal saline to make a final volume of 3.5 ml)and 15 ml of sterile normal saline by intravenous route .  Patients will receive ultrasound guided preoperative stellate ganglion block with 3.5 ml of solution (3 ml 2 % lignocaine plus 0.5 ml of normal saline to make a final volume of 3.5 ml)and 15 ml of sterile normal saline by intravenous route . 
Comparator Agent  Group 3- pateints will recieve preoperative stellate ganglion block with 3.5 ml of a solution(3 ml 2% lignocaine plus 0.5 ml of normal saline to make a final volume of 3.5 ml )and 0.5 microgram/ kg of dexmedetomidine diluted in 15 of sterile normal saline by intravenous route.  Pateints will recieve preoperative stellate ganglion block with 3.5 ml of a solution(3 ml 2% lignocaine plus 0.5 ml of normal saline to make a final volume of 3.5 ml )and 0.5 microgram/ kg of dexmedetomidine diluted in 15 of sterile normal saline by intravenous route. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. ASA physical status I &II of either sex
2. Age between 18 to 60 years
3. BMI between 20 to 30 kg m-2
4. Scheduled for upper limb surgery
 
 
ExclusionCriteria 
Details  1. Patient’s refusal for the procedure.
2. Patients having history of substance abuse.
3. Patients with coagulopathy and bleeding disorders.
4. Pre existing peripheral neuropathy.
5. Pre existing local infection at the site of block.
6. Pregnant and lactating women.
7. Patients having inability to use PCA pump.
8. Contraindication to study drug lignocaine, dexmedetomidine and tramadol.
9. Patients on chronic pain management drugs.
10. Patients with simultaneous acute post operative pain in other parts of the body.
11. Contraindication to general anaesthesia.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To study tramadol sparing effect of dexmedetomidine as an adjuvant with lignocaine in preoperative stellate ganglion block for postoperative pain relief following upper limb surgeries.  In post anaesthesia care unit 0 hours
2 hours
4 hours
6 hours
8 hours
12 hours
24 hours
36 hours
48 hours 
 
Secondary Outcome  
Outcome  TimePoints 
Preoperative -haemodynamics,VAS at rest and on movement,temperature in operative limb, eye signs(chemosis,ptosis,miosis) and ramsay sedation score;Intraoperatively-haemodynamics,oxygen saturation,end tidal Et CO2;
Post operatively-haemodynamics,VAS at rest and on movement,adverse effects,ramsay sedation score and patient satisfaction score. 
preoperatively-baseline,5 min after block and every 5 mins till 15 min after block placement;Intraoperatively every 5 mins till end of surgery;postoperatively 0 hours,2 hours,4 hours,6 hours,8 hours,12 hours,24 hours,36 hours and 48 hours.  
 
Target Sample Size   Total Sample Size="54"
Sample Size from India="54" 
Final Enrollment numbers achieved (Total)= "54"
Final Enrollment numbers achieved (India)="54" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   02/03/2015 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Published in the BRITish Journal of pain  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
In recent years greater emphasis is being laid on the management of post operative pain relief..Peripheral nerve blocks for upper limb surgeries have shown to provide better outcome in terms of pain relief and patient statisfaction .Peripheral nerve blocks are also associated with enhanced participation of patients in rehabilitation phase thus reducing hospital cost and stay.Role of autonomic nervous system in control of chronic pain has been described in literature in patients of complex regional pain syndrome. Mc Donell et al have demonstrated the role of autonomic nervous system in management of acute post operative pain .In his case series preoperative stellate ganglion block was given to patients undergoing operative treatment for humerus fractures and effective postoperative analgesia was reported upto 48 hours.Further a recent randomised control trial conducted by Kumar et al demonstrated a postoperative tramadol sparing effect following preoperative stellate ganglion in patients undergoing upper limb orthopaedic surgery under general anaesthesia.The role of stellate ganglion block in postoperative pain relief has now been establised for upper limb surgeries.Literature describes the role of various adjuvants to peripheral nerve blocks .As most patients report increased pain during night hours when access to care is limited adjuvants have been used to increase duration of pain relief as well as requirement of analgesic medication postoperatively.Dexmedetomidine is an alpha 2 agonist having both sedative and analgesic properties. Use of dexmedetomidine  in various nerve blocks as an adjuvant and also in cervical plexsus block has shown to shorten the sensory block  onset time and extended the duration of analgesia.A through search of literature did not reveal any study using dexmedetomidine as an adjuvant with local anaesthetic in stellate ganglion block .We hypothesise that the addition of dexmedetomidine to lignocaine during preoperative ultrasound guided stellate ganglion block will have no effect on postoperative cumulative tramadol consumption at 48 hours in patients scheduled for upper limb surgeries under general anaesthesia.

Sample size calculation-As per a pilot study conducted for tramadol sparing effect of preoperative stellate ganglion block for postoperative pain relief in patients undergoing upper limb surgeries the mean tramadol consumption came out to be 130 mg with standard deviation of 14.1.To estimate a difference of consumption of 10 % tramadol our sample size came out to be 15 patients per group ,with a power of 80% and confidence interval of 95%.Considering a drop out rate of 20 % the sample size came out to be 18 patients in each group.

Primary outcome-To study tramadol sparing effect of dexmedetomidine as an adjuvant with lignocaine in preoperative stellate ganglion block for postoperative pain relief following upper limb surgeries.
Secondary outcome-To study perioperative pain relief ,haemodynamics  and adverse effects of preoperative stellate ganglion block in patients scheduled for upper limb surgeries.

Result : The cumulative tramadol consumption at the end of 48 hours (p=0.01) was significantly reduced in the group I as compared to group II . In group I postoperative vas at rest was significantly reduced up to n12 hours potoperatively as compared to group II (p= 0.05). the cumulative tramadol consumpotion was not reduced significantly in group III compared to group II (p=0.51).



 
Close